Both focal and diffuse brain injury pathologies have been suggested to be linked to destructive calcium-mediated processes. One likely mediator of such intracellular auto-destructive processes is the calpain family of neutral proteases. Calpains are calcium-activated and are capable of effecting the limited proteolysis of many intracellular proteins, allowing for transient or permanent alterations in cellular function or structural integrity. The central hypothesis of Project 2 is that traumatic brain injury leads to activation of calpains which subsequently degrade neurofilament proteins, structural elements which may play an important role in resistance to and recovery from injury. The long range goals of the project are twofold: 1) to identify the distinct features of calpain activation and NF damage for white matter and gray matter injuries in order to develop more effective, targeted therapeutic strategies for calpain inhibition following brain injury, and 2) to identify the potential roles for NFs in modulating the initial impact of mechanical trauma and in influencing the progression of trauma-induced neuropathology. To achieve these goals, we propose in Aim 1 to establish the patterns of activation of calpains I and II and associated NF damage in brain-injured humans and use this information to validate the well-characterized rat model of lateral fluid percussion injury, which mimics the mixture of gray and white matter pathology commonly seen in humans.
In Aim 2, we propose to study, in the mouse, gray matter and white matter pathology in isolation, using the controlled cortical impact (CCI) model and the optic nerve stretch model. This will allow us to directly compare the time course of calpain activation and NF damage in gray vs. white matter regions to reestablish targeting strategies for therapy. The proteolytic events observed in mouse optic nerve injury will then be confirmed using a model of diffuse axonal injury (DAI) in the pig which closely reproduces human DAI pathology.
In Aim 3 we will return to the mouse CCI model to exploit the availability of genetically altered (transgenic and knockout) mice to mechanistically explore the role of NFs in trauma-induced pathology, behavioral dysfunction and gene expression. We hope that increased understanding of the role of NFs in trauma and their relationship to calpain-mediated pathology may lead to improve therapies aimed at inhibition of calpain and the development of novel therapeutic approaches targeting the neurofilamentous cytoskeleton.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
3P50NS008803-28A2S1
Application #
6417704
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2000-09-30
Project End
2001-08-31
Budget Start
Budget End
Support Year
28
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nariai, Hiroki; Duberstein, Susan; Shinnar, Shlomo (2018) Treatment of Epileptic Encephalopathies: Current State of the Art. J Child Neurol 33:41-54
Nariai, Hiroki; Beal, Jules; Galanopoulou, Aristea S et al. (2017) Scalp EEG Ictal gamma and beta activity during infantile spasms: Evidence of focality. Epilepsia 58:882-892
Tomasevic, Gregor; Laurer, Helmut L; Mattiasson, Gustav et al. (2012) Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA. J Neurosurg 116:1368-78
Browne, Kevin D; Chen, Xiao-Han; Meaney, David F et al. (2011) Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma 28:1747-55
Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe et al. (2010) Deletion of the p53 tumor suppressor gene improves neuromotor function but does not attenuate regional neuronal cell loss following experimental brain trauma in mice. J Neurosci Res 88:3414-23
Hånell, Anders; Clausen, Fredrik; Björk, Maria et al. (2010) Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 27:1297-309
Marklund, N; Morales, D; Clausen, F et al. (2009) Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience 163:540-51
Marklund, Niklas; Bareyre, Florence M; Royo, Nicolas C et al. (2007) Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg 107:844-53
Keck, Carrie A; Thompson, Hilaire J; Pitkanen, Asla et al. (2007) The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury. Restor Neurol Neurosci 25:77-90
Serbest, Gulyeter; Burkhardt, Matthew F; Siman, Robert et al. (2007) Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice. Neurochem Res 32:2006-14

Showing the most recent 10 out of 71 publications